Global IVD Antibodies Market Size study, By Product Type (Cardiac Markers, Tumor Markers, Kidney Injury Markers, Infection and Inflammation Antibodies), By Application (Immunology, Cancer, Cardiovascular Diseases), By End User (Hospitals, Diagnostic Laboratories, Homecare Settings, Others), and Regional Forecasts 2022-2028

BIZ4983408
200 Pages
July 2022
Pharmaceuticals

Download Sample Get Discount

Global IVD Antibodies Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. The IVD Antibodies or In Vitro Diagnostics (IVD) Antibodies refers to diagnostic tools utilized for clinical diagnostics and research applications. These are used in combination with diagnostic assays to detect and diagnose numerous chronic and infectious diseases including cancer, tuberculosis, HIV etc. The growing prevalence of chronic and infectious diseases and increasing number of proteomics and genomics research activities as well as strategic initiatives from leading market players are factors that are accelerating the global market demand. For instance, according to World health Organization Estimates – as of 2021, globally around 41 million people succumbs to Noncommunicable diseases (NCDs), representing around 71% of all global deaths. Cardiovascular diseases account for highest number of NCD death, or 17.9 million deaths annually, followed by cancers (9.3 million deaths), respiratory diseases (4.1 million deaths), and diabetes (1.5 million deaths). Furthermore, leading market players are coming up with new products to leverage the growing adoption of antibody based invitro diagnostics products. For instance, in May 2020, Biocare unveiled seven novel IVD IHC antibody markers for clinical diagnostics and research applications. Biocare redeveloped its S100 protein antibody and launched one mouse monoclonal and five novel rabbit monoclonal antibodies in the immuno-oncology space: CTLA-4 [CAL49], GITR [CAL8], LAG3 [CAL26], PD-1 [CAL20], CD22 (M) [BLCAM/1796], and E-cadherin [CDH1/2208R]. Also, growing R&D spending in healthcare sector as well as rising emergence of antibodies-based diagnostic products are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, a high cost associated with IVD antibodies coupled with low penetration rate in emerging markets impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global IVD Antibodies Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing prevalence of cancer and cardiovascular diseases as well as presence of leading market players. Whereas, Asia pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as rising incidences of infectious diseases and surging healthcare infrastructure in the region, would create lucrative growth prospects for the global IVD Antibodies Market across the North American region.

Major market players included in this report are:

Thermo Fisher Scientific

Rockland Immunochemicals Inc.

Abcam plc.

SDIX, LLC.

GenScript

Bio-Rad Laboratories, Inc.

HyTest Ltd.

Advy Chemical Pvt. Ltd.

MEDICAL & BIOLOGICAL LABORATORIES CO., LTD.

Abbott

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Cardiac Markers

Tumor Markers

Kidney Injury Markers

Infection and Inflammation Antibodies

By Application:

Immunology

Cancer

Cardiovascular Diseases

By End User:

Hospitals

Diagnostic Laboratories

Homecare Settings

Others

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global IVD Antibodies Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)

1.2.1. Global IVD Antibodies Market, by Region, 2020-2028 (USD Million)

1.2.2. Global IVD Antibodies Market, by Product Type, 2020-2028 (USD Million)

1.2.3. Global IVD Antibodies Market, by Application, 2020-2028 (USD Million)

1.2.4. Global IVD Antibodies Market, by End User, 2020-2028 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global IVD Antibodies Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global IVD Antibodies Market Dynamics

3.1. IVD Antibodies Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Rising prevalence of chronic and infectious diseases

3.1.1.2. Increasing number of proteomics and genomics research activities.

3.1.1.3. Strategic initiatives from leading market players.

3.1.2. Market Challenges

3.1.2.1. High cost associated with IVD antibodies.

3.1.2.2. Low penetration rate in emerging markets.

3.1.3. Market Opportunities

3.1.3.1. Growing R&D spending in healthcare sector.

3.1.3.2. Rising emergence of antibodies-based diagnostic products

Chapter 4. Global IVD Antibodies Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global IVD Antibodies Market, by Product Type

6.1. Market Snapshot

6.2. Global IVD Antibodies Market by Product Type, Performance - Potential Analysis

6.3. Global IVD Antibodies Market Estimates & Forecasts by Product Type 2018-2028 (USD Million)

6.4. IVD Antibodies Market, Sub Segment Analysis

6.4.1. Cardiac Markers

6.4.2. Tumor Markers

6.4.3. Kidney Injury Markers

6.4.4. Infection and Inflammation Antibodies

Chapter 7. Global IVD Antibodies Market, by Application

7.1. Market Snapshot

7.2. Global IVD Antibodies Market by Application, Performance - Potential Analysis

7.3. Global IVD Antibodies Market Estimates & Forecasts by Application 2018-2028 (USD Million)

7.4. IVD Antibodies Market, Sub Segment Analysis

7.4.1. Immunology

7.4.2. Cancer

7.4.3. Cardiovascular Diseases

Chapter 8. Global IVD Antibodies Market, by End User

8.1. Market Snapshot

8.2. Global IVD Antibodies Market by End User, Performance - Potential Analysis

8.3. Global IVD Antibodies Market Estimates & Forecasts by End User 2018-2028 (USD Million)

8.4. IVD Antibodies Market, Sub Segment Analysis

8.4.1. Hospitals

8.4.2. Diagnostic Laboratories

8.4.3. Homecare Settings

8.4.4. Others

Chapter 9. Global IVD Antibodies Market, Regional Analysis

9.1. IVD Antibodies Market, Regional Market Snapshot

9.2. North America IVD Antibodies Market

9.2.1. U.S. IVD Antibodies Market

9.2.1.1. Product Type estimates & forecasts, 2018-2028

9.2.1.2. Application estimates & forecasts, 2018-2028

9.2.1.3. End User estimates & forecasts, 2018-2028

9.2.2. Canada IVD Antibodies Market

9.3. Europe IVD Antibodies Market Snapshot

9.3.1. U.K. IVD Antibodies Market

9.3.2. Germany IVD Antibodies Market

9.3.3. France IVD Antibodies Market

9.3.4. Spain IVD Antibodies Market

9.3.5. Italy IVD Antibodies Market

9.3.6. Rest of Europe IVD Antibodies Market

9.4. Asia-Pacific IVD Antibodies Market Snapshot

9.4.1. China IVD Antibodies Market

9.4.2. India IVD Antibodies Market

9.4.3. Japan IVD Antibodies Market

9.4.4. Australia IVD Antibodies Market

9.4.5. South Korea IVD Antibodies Market

9.4.6. Rest of Asia Pacific IVD Antibodies Market

9.5. Latin America IVD Antibodies Market Snapshot

9.5.1. Brazil IVD Antibodies Market

9.5.2. Mexico IVD Antibodies Market

9.6. Rest of The World IVD Antibodies Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Thermo Fisher Scientific

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Rockland Immunochemicals Inc.

10.2.3. Abcam plc.

10.2.4. SDIX, LLC.

10.2.5. GenScript

10.2.6. Bio-Rad Laboratories, Inc.

10.2.7. HyTest Ltd.

10.2.8. Advy Chemical Pvt. Ltd.

10.2.9. MEDICAL & BIOLOGICAL LABORATORIES CO., LTD.

10.2.10. Abbott

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global IVD Antibodies Market, report scope

TABLE 2. Global IVD Antibodies Market estimates & forecasts by Region 2018-2028 (USD Million)

TABLE 3. Global IVD Antibodies Market estimates & forecasts by Product Type 2018-2028 (USD Million)

TABLE 4. Global IVD Antibodies Market estimates & forecasts by Application 2018-2028 (USD Million)

TABLE 5. Global IVD Antibodies Market estimates & forecasts by End User 2018-2028 (USD Million)

TABLE 6. Global IVD Antibodies Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 7. Global IVD Antibodies Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 8. Global IVD Antibodies Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 9. Global IVD Antibodies Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 10. Global IVD Antibodies Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 11. Global IVD Antibodies Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 12. Global IVD Antibodies Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 13. Global IVD Antibodies Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 14. Global IVD Antibodies Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 15. Global IVD Antibodies Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 16. U.S. IVD Antibodies Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 17. U.S. IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 18. U.S. IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 19. Canada IVD Antibodies Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 20. Canada IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 21. Canada IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 22. UK IVD Antibodies Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 23. UK IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 24. UK IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 25. Germany IVD Antibodies Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 26. Germany IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 27. Germany IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 28. RoE IVD Antibodies Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 29. RoE IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 30. RoE IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 31. China IVD Antibodies Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 32. China IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 33. China IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 34. India IVD Antibodies Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 35. India IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 36. India IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 37. Japan IVD Antibodies Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 38. Japan IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 39. Japan IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 40. RoAPAC IVD Antibodies Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 41. RoAPAC IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 42. RoAPAC IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 43. Brazil IVD Antibodies Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 44. Brazil IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 45. Brazil IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 46. Mexico IVD Antibodies Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 47. Mexico IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 48. Mexico IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 49. RoLA IVD Antibodies Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 50. RoLA IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 51. RoLA IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 52. Row IVD Antibodies Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 53. Row IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 54. Row IVD Antibodies Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 55. List of secondary sources, used in the study of global IVD Antibodies Market

TABLE 56. List of primary sources, used in the study of global IVD Antibodies Market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara